Literature DB >> 20513801

Identification of cellular targets in human intrahepatic cholangiocarcinoma using laser microdissection and accurate mass and time tag proteomics.

Alexandre Dos Santos1, Magali Court, Valérie Thiers, Sokhavuth Sar, Catherine Guettier, Didier Samuel, Christian Bréchot, Jérôme Garin, France Demaugre, Christophe D Masselon.   

Abstract

Obtaining accurate protein profiles from homogeneous cell populations in heterogeneous tissues can enhance the capability to discover protein biomarkers. In this context, methodologies to access specific cellular populations and analyze their proteome with exquisite sensitivity have to be selected. We report here the results of an investigation using a combination of laser microdissection and accurate mass and time tag proteomics. The study was aimed at the precise determination of proteome alterations in intrahepatic cholangiocarcinoma ICC, a markedly heterogeneous tumor. This cancer, which is difficult to diagnose and carries a very poor prognosis, has shown an unexplained increase in incidence over the last few years. Among a pool of 574 identified proteins, we were able to report on altered abundance patterns affecting 39 proteins conforming to a variety of potential tumorigenic pathways. The reliability of the proteomics results was confirmed by Western blot and immunohistochemistry on matched samples. Most of the proteins displaying perturbed abundances had not yet been described in the setting of ICC. These include proteins involved in cell mobility and actin cytoskeleton remodeling, which may participate in the epithelial to mesenchymal transition, a process invoked in migration and invasion of cancer cells. The biological relevance of these findings was explored using a tissue microarray. An increased abundance of vimentin was thus detected in 70% of ICC and none of the controls. These results suggest that vimentin could play a role in the aggressiveness of ICC and provide a basis for the serious outcome of this cancer.

Entities:  

Mesh:

Year:  2010        PMID: 20513801      PMCID: PMC2938110          DOI: 10.1074/mcp.M110.000026

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  83 in total

1.  Accurate qualitative and quantitative proteomic analysis of clinical hepatocellular carcinoma using laser capture microdissection coupled with isotope-coded affinity tag and two-dimensional liquid chromatography mass spectrometry.

Authors:  Chen Li; Yi Hong; Ye-Xiong Tan; Hu Zhou; Jian-Hua Ai; Su-Jun Li; Lei Zhang; Qi-Chang Xia; Jia-Rui Wu; Hong-Yang Wang; Rong Zeng
Journal:  Mol Cell Proteomics       Date:  2004-01-15       Impact factor: 5.911

2.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

Review 3.  TGF-beta and epithelial-to-mesenchymal transitions.

Authors:  Jiri Zavadil; Erwin P Böttinger
Journal:  Oncogene       Date:  2005-08-29       Impact factor: 9.867

4.  Different expression of calgizzarin (S100A11) in normal colonic epithelium, adenoma and colorectal carcinoma.

Authors:  Christian Melle; Günther Ernst; Bettina Schimmel; Annett Bleul; Henning Mothes; Roland Kaufmann; Utz Settmacher; Ferdinand Von Eggeling
Journal:  Int J Oncol       Date:  2006-01       Impact factor: 5.650

5.  A toolbox for validation of mass spectrometry peptides identification and generation of database: IRMa.

Authors:  Véronique Dupierris; Christophe Masselon; Magali Court; Sylvie Kieffer-Jaquinod; Christophe Bruley
Journal:  Bioinformatics       Date:  2009-05-06       Impact factor: 6.937

6.  Intrahepatic cholangiocarcinoma escapes from growth inhibitory effect of transforming growth factor-beta1 by overexpression of cyclin D1.

Authors:  Yoh Zen; Kenichi Harada; Motoko Sasaki; Tse-Ching Chen; Miin-Fu Chen; Ta-Sen Yeh; Yi-Yin Jan; Shiu-Feng Huang; Yuji Nimura; Yasuni Nakanuma
Journal:  Lab Invest       Date:  2005-04       Impact factor: 5.662

7.  Overexpression of vimentin contributes to prostate cancer invasion and metastasis via src regulation.

Authors:  Juncheng Wei; Gang Xu; Mingfu Wu; Yongtao Zhang; Qiong Li; Ping Liu; Tao Zhu; Anping Song; Liangpin Zhao; Zhiqiang Han; Gang Chen; Shixuan Wang; Li Meng; Jianfeng Zhou; Yunping Lu; Shixuan Wang; Ding Ma
Journal:  Anticancer Res       Date:  2008 Jan-Feb       Impact factor: 2.480

8.  Colorectal cancer progression correlates with upregulation of S100A11 expression in tumor tissues.

Authors:  Guiyu Wang; Xishan Wang; Shuhuai Wang; Hongtao Song; Haiming Sun; Weiguang Yuan; Bo Cao; Jing Bai; Songbin Fu
Journal:  Int J Colorectal Dis       Date:  2008-03-14       Impact factor: 2.571

9.  Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: A population-based study of U.S. veterans.

Authors:  Hashem B El-Serag; Eric A Engels; Ola Landgren; Elizabeth Chiao; Louise Henderson; Harshinie C Amaratunge; Thomas P Giordano
Journal:  Hepatology       Date:  2009-01       Impact factor: 17.425

10.  Serotonin metabolism is dysregulated in cholangiocarcinoma, which has implications for tumor growth.

Authors:  Gianfranco Alpini; Pietro Invernizzi; Eugenio Gaudio; Julie Venter; Shelley Kopriva; Francesca Bernuzzi; Paolo Onori; Antonio Franchitto; Monique Coufal; Gabriel Frampton; Domenico Alvaro; Sum P Lee; Marco Marzioni; Antonio Benedetti; Sharon DeMorrow
Journal:  Cancer Res       Date:  2008-11-15       Impact factor: 12.701

View more
  13 in total

Review 1.  Beyond laser microdissection technology: follow the yellow brick road for cancer research.

Authors:  Luc G Legres; Anne Janin; Christophe Masselon; Philippe Bertheau
Journal:  Am J Cancer Res       Date:  2014-01-15       Impact factor: 6.166

Review 2.  Cancer biomarker discovery for cholangiocarcinoma: the high-throughput approaches.

Authors:  Atit Silsirivanit; Kanlayanee Sawanyawisuth; Gregory J Riggins; Chaisiri Wongkham
Journal:  J Hepatobiliary Pancreat Sci       Date:  2014-02-12       Impact factor: 7.027

3.  Differential Protein Expression Marks the Transition From Infection With Opisthorchis viverrini to Cholangiocarcinoma.

Authors:  Jarinya Khoontawad; Chawalit Pairojkul; Rucksak Rucksaken; Porntip Pinlaor; Chaisiri Wongkham; Puangrat Yongvanit; Ake Pugkhem; Alun Jones; Jordan Plieskatt; Jeremy Potriquet; Jeffery Bethony; Somchai Pinlaor; Jason Mulvenna
Journal:  Mol Cell Proteomics       Date:  2017-02-23       Impact factor: 5.911

4.  Gamma-smooth muscle actin expression is associated with epithelial-mesenchymal transition and stem-like properties in hepatocellular carcinoma.

Authors:  Nassima Benzoubir; Charlotte Mussini; Charlène Lejamtel; Alexandre Dos Santos; Claire Guillaume; Christophe Desterke; Didier Samuel; Christian Bréchot; Marie-Françoise Bourgeade; Catherine Guettier
Journal:  PLoS One       Date:  2015-06-25       Impact factor: 3.240

5.  Identification of a novel BET bromodomain inhibitor-sensitive, gene regulatory circuit that controls Rituximab response and tumour growth in aggressive lymphoid cancers.

Authors:  Anouk Emadali; Sophie Rousseaux; Juliana Bruder-Costa; Claire Rome; Samuel Duley; Sieme Hamaidia; Patricia Betton; Alexandra Debernardi; Dominique Leroux; Benoit Bernay; Sylvie Kieffer-Jaquinod; Florence Combes; Elena Ferri; Charles E McKenna; Carlo Petosa; Christophe Bruley; Jérôme Garin; Myriam Ferro; Rémy Gressin; Mary B Callanan; Saadi Khochbin
Journal:  EMBO Mol Med       Date:  2013-07-04       Impact factor: 12.137

6.  Septin 9 induces lipid droplets growth by a phosphatidylinositol-5-phosphate and microtubule-dependent mechanism hijacked by HCV.

Authors:  Abdellah Akil; Juan Peng; Mohyeddine Omrane; Claire Gondeau; Christophe Desterke; Mickaël Marin; Hélène Tronchère; Cyntia Taveneau; Sokhavuth Sar; Philippe Briolotti; Soumaya Benjelloun; Abdelaziz Benjouad; Patrick Maurel; Valérie Thiers; Stéphane Bressanelli; Didier Samuel; Christian Bréchot; Ama Gassama-Diagne
Journal:  Nat Commun       Date:  2016-07-15       Impact factor: 14.919

7.  Identification of Four Immune Subtypes Characterized by Distinct Composition and Functions of Tumor Microenvironment in Intrahepatic Cholangiocarcinoma.

Authors:  Sylvie Job; Delphine Rapoud; Alexandre Dos Santos; Patrick Gonzalez; Christophe Desterke; Gérard Pascal; Nabila Elarouci; Mira Ayadi; René Adam; Daniel Azoulay; Denis Castaing; Eric Vibert; Daniel Cherqui; Didier Samuel; Antonio Sa Cuhna; Agnès Marchio; Pascal Pineau; Catherine Guettier; Aurélien de Reyniès; Jamila Faivre
Journal:  Hepatology       Date:  2020-08-16       Impact factor: 17.425

8.  Comparative proteomic profiling of human bile reveals SSP411 as a novel biomarker of cholangiocarcinoma.

Authors:  Jian Shen; Weizhi Wang; Jindao Wu; Bing Feng; Wen Chen; Meng Wang; Jincao Tang; Fuqiang Wang; Feng Cheng; Liyong Pu; Qiyun Tang; Xuehao Wang; Xiangcheng Li
Journal:  PLoS One       Date:  2012-10-31       Impact factor: 3.240

9.  Clinicopathological and prognostic significance of epithelial mesenchymal transition-related protein expression in intrahepatic cholangiocarcinoma.

Authors:  Xing Yao; Xiang Wang; Zishu Wang; Licheng Dai; Guolei Zhang; Qiang Yan; Weimin Zhou
Journal:  Onco Targets Ther       Date:  2012-10-12       Impact factor: 4.147

Review 10.  [Proteomics and translational medicine: molecular biomarkers for cancer diagnosis, prognosis and prediction of therapy outcome].

Authors:  William C S Cho
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2011-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.